EFA ETF: What Is It? - A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
The iShares MSCI EAFE ETF (EFA) is a broad, diversified developed-market core holding that excludes the US and Canada, with deep liquidity, an active options market, and steady dividends as its key strengths. The main selection criteria come down to expense and options-market differences when compared with IEFA, VEA, and VXUS.
What Is the iShares MSCI EAFE ETF?
It is a passive ETF managed by iShares (BlackRock) that tracks the MSCI EAFE Index. It holds large- and mid-cap stocks from developed markets outside the US and Canada using a market-cap-weighted approach.
It is well suited for global traders who actively use liquidity and the options market, as well as institutional asset allocators seeking developed-market exposure outside the US and Canada.
It is an ETF managed by iShares (BlackRock) using a passive (index-tracking) investment approach.
How to Invest in the iShares MSCI EAFE ETF?
| Item | Details |
|---|---|
| Tracking Index | MSCI EAFE |
| Management Style | Passive (Index Tracking) |
| Coverage | Large- and mid-cap developed-market stocks, excluding the US and Canada |
| Dividend Schedule | Semi-annual dividends |
| Total Expense Ratio | 0.32% |
| Fund Manager | iShares (BlackRock) |
It employs a passive strategy designed to provide broad, diversified exposure to large- and mid-cap stocks across MSCI-classified developed markets outside the US and Canada. Even among other ETFs tracking the MSCI EAFE Index, its key differentiators are a deep options market and a robust institutional trading infrastructure.
- Deep options and futures market
- Institutional-trading standard among global ETFs
- Broad diversification through MSCI EAFE tracking
Size and Cost of the iShares MSCI EAFE ETF (AUM and Expense Ratio)
Assets under management (AUM) stand at $76.1B, with a total expense ratio of 0.32% annually.
IEFA, shown in the table, also tracks the MSCI EAFE Index but serves as a direct alternative with a lower expense ratio, while VEA tracks the FTSE Developed Markets Index, a variant with differences in how Korea and Canada are classified. VXUS and VEU offer broader exposure that includes emerging markets, and VT is a worldwide-exposure variant that also includes the United States.
Performance and Flows of the iShares MSCI EAFE ETF
It has shown a trajectory with relatively lower volatility compared to the US market, though short-term volatility has at times expanded during periods of multi-currency FX swings and cyclical shifts in Europe and Japan.
It belongs to the mega global ETF category, which attracts both global diversification demand and institutional hedging and trading flows. Inflows have also been particularly notable when US market valuation concerns come into focus.
Strengths and Weaknesses of the iShares MSCI EAFE ETF
A deep options market and its status as an institutional trading standard are its primary strengths, while a somewhat higher expense ratio compared with IEFA and FX exposure are weaknesses worth considering in advance.
💪 Key Strengths
⚠️ Points to Watch
Alternative ETFs and Related Products to the iShares MSCI EAFE ETF
IEFA and VEA, shown in the table, are direct alternative variants with lower expense ratios, while VXUS and VEU are broader non-US exposure variants that also include emerging markets, and VT is a global diversification ETF that includes the United States. If you want to add a separate emerging-market sleeve, variants such as VWO and IEMG are also worth reviewing.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| Vanguard FTSE Developed Markets ETF | $69.33 | +0.4% | $226.4B | 0.03% | 2.46% | +13.3% | |
| iShares Core MSCI EAFE ETF | $95.96 | +0.3% | $188.2B | 0.07% | 3.43% | +8.2% | |
| Vanguard Total International Stock ETF | $82.63 | +0.1% | $160.0B | 0.05% | 2.4% | +10.3% | |
| Vanguard Total World Stock ETF | $156.64 | +0.5% | $81.8B | 0.06% | 1.54% | +11.7% | |
| Schwab International Equity ETF | $26.90 | +0.4% | $66.9B | 0.03% | 3.13% | +12.8% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| ASML | ASML Holding NV | 0.05% | $1590.90 | +1.2% | $613.2B | 39.2 | 0.65% |
| HSBC | HSBC Holdings plc ADR | 0.03% | $91.21 | +0.6% | $312.6B | 13.1 | 4.58% |
| AZN | Astrazeneca plc | 0.03% | $172.06 | +0.3% | $266.8B | 25.7 | 1.94% |
| NVS | Novartis AG ADR | 0.03% | $153.81 | +1.8% | $281.6B | 23.2 | 2.83% |
| Shell plc ADRhedged | 0.02% | $77.76 | -1.0% | $0.0M | - | 1.57% |
Investor Checkpoints for the iShares MSCI EAFE ETF
Here are the key checkpoints to review before investing in EFA. Its deep options market and status as an institutional trading standard are clear strengths, but the somewhat higher expense ratio versus IEFA, multi-currency FX exposure, and the absence of emerging markets should be reviewed once more before buying, along with position sizing and trading frequency.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Expense gap vs. IEFA and VEA | Somewhat higher |
| 💧 Liquidity | Depth of options and futures markets | Top-tier |
| 💱 Multi-Currency FX | Impact of euro, yen, and pound conversion | Unhedged |
| 📊 Emerging-Market Inclusion | Need for separate emerging-market supplement | Not included |
The expense gap, multi-currency FX exposure, and absence of emerging markets are the main drivers of short-term volatility and trading efficiency. If you frequently use options and hedging strategies, EFA is the appropriate choice, while IEFA and VEA are better suited for investors prioritizing a long-term buy-and-hold approach.
If liquidity and options-market depth are the top priorities, EFA is regarded as the standard choice. If minimizing expenses is the priority, IEFA and VEA are suitable alternatives; for broader exposure including emerging markets, VXUS and VEU are the appropriate variants, and VT is the right pick for global exposure.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of May 22, 2026.